Substance P, the Immune System and Inflammation

References

• Pernow B., Substance P. Pharmacol Rev 1983; 35: 85–141
   PubMed Web of Science ®Google Scholar
• Substance P and Neurokinins, J.L. Henry, R. Couture, A.C. Cuello, G. Pelletier, R. Quirion, D. Regoli. Springer-Verlag, New York 1987
   Google Scholar
• Substance P—Metabolism and Biological Actions, C.C. Jordan, P. Oehme. Taylor & Francis, London and Philadelphia 1985
   Google Scholar
• Fone K.C.F., Bennett G.W., Marsden C.A. Regional distribution of Substance P and thyrotropin-releasing hormone-like immunoreactivity and indoleamines in the rabbit spinal cord. J. Neurochem 1987; 48: 1027–1032
   Google Scholar
• Nakanishi S. Substance P precursor and kininogen: their structures, gene organizations and regulation. Physiol. Rev 1987; 67: 1117–1142
   PubMed Web of Science ®Google Scholar
• Otsuka M., Konishi S. Substance P the first peptide neurotransmitter. Trends Neurosci 1983; 6: 317–320
   Google Scholar
• Lembeck F., Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch. Pharmacol 1979; 310: 175–183
   PubMed Web of Science ®Google Scholar
• Bar-Shavit Z., Goldman R., Stabinsky Y., Gottlieb P., Fridkin M., Teichberg V.I., Blumberg S. Enhancement of phagocytosis—a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem. Biophys. Res. Commun 1980; 94: 1445
   PubMed Web of Science ®Google Scholar
• Nathan C.F. Secretory products of macrophages. J. Clin. Invest 1987; 79: 319–326
   PubMed Web of Science ®Google Scholar
• Klebanoff S.J. Phagocytic cells: products of oxygen metabolism. Inflammation: Basic Principles and Clinical Correlates, J.I. Gallin, I.M. Goldstein, R. Snyderman. Raven Press, New York 1988; 391–444
   Google Scholar
• Hartung H.P., Toyka K.V. Activation of macrophages by Substance P: induction of oxidative burst and thromboxane release. Eur. J. Pharmacol 1983; 89: 301–305
   PubMed Web of Science ®Google Scholar
• Peck R. Neuropeptides modulating macrophage function. Ann. N.Y. Acad. Sci 1987; 496: 264–270
   PubMed Web of Science ®Google Scholar
• Hartung H.P., Hadding U., Bitter-Suermann D., Gemsa D. Stimulation of prostaglandin E and thromboxane synthesis in macrophages by purified C3b. J. Immunol 1983; 130: 2861–2865
   Google Scholar
• Hartung H.P., Wolters K., Toyka K.V. Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J. Immunol 1986; 136: 3856–3863
   PubMed Web of Science ®Google Scholar
• Rugg M.R., Wahl S.M., Pert C.B. Substance P receptor-mediated chemotaxis of human monocytes. Peptides 1985; 6(suppl. 2)107–111
   Google Scholar
• Kimball E.S., Persico F.J., Vaught J.L. Substance P, neurokinin A, and neurokinin B induce generation of IL-1-like activity in P388D1 cells. J. Immunol 1988; 141: 3564–3569
   PubMed Web of Science ®Google Scholar
• Cozens P.J., Rowe F.M. Substance P is a potent inducer of TNF and II-1 secretion by macrophages. A potential role for TNF in the pathogenesis of asthma. Immunobiol 1987; 175: 7
   Web of Science ®Google Scholar
• Marasco W.A., Showell H.J., Becker E.L. Substance P binds to the formylpeptide chemotaxis receptor on the rabbit neutrophil. Biochem. Biophys. Res. Comm 1981; 99: 1065–1072
   PubMed Web of Science ®Google Scholar
• Roch-Arvellier M., Regoli D., Chanaud B., Lenoir M., Muntaner O., Stralzko S., Giroud J.-P. Tachykinins: effects on motility and metabolism of polymorphonuclear leukocytes. Pharmacology 1986; 33: 266–273
   Google Scholar
• Fewtrell C.M.S., Foreman J.C., Jordan C.C., Oehme P., Renner H., Stewart J.M. The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J. Physiol 1982; 330: 393–411
   PubMed Web of Science ®Google Scholar
• Piotrowski W., Devoy M.A.B., Jordan C.C., Foreman J.C. The substance P receptor on rat mast cells and in human skin. Agents and Actions 1984; 14: 420–424
   PubMedGoogle Scholar
• Ali H., Leung K.B.P., Pearce F.L., Hayes N.A., Foreman J.C. Comparison of the histamine-releasing action of substance P on mast cells and basophils from different species and tissues. Int. Arch. Allergy Appl. Immun 1986; 79: 413–418
   PubMedGoogle Scholar
• Coleman J.W., Huang Q., Stanworth D.R. The mast cell response to Substance P: effects of neuraminidase, limulin, and some novel synthetic peptide antagonists. Peptides 1986; 7: 171–175
   Google Scholar
• Shibata H., Mio M., Tasaka K. Analysis of the mechanism of histamine release induced by substance E. Biochim. Biophys. Acta 1985; 846: 1–7
   PubMed Web of Science ®Google Scholar
• Payan D.G., McGillis J.P., Goetzl E.J. Neuroimmunology. Adv. Immunol 1986; 39: 299–323
   PubMed Web of Science ®Google Scholar
• Foreman J.C. Peptides and neurogenic inflammation. Br. Med. Bull 1987; 43: 386–400
   PubMed Web of Science ®Google Scholar
• White M.V., Kaliner M.A. Histamine. Inflammation: Basic Principles and Clinical Correlates, J.I. Gallin, I.M. Goldstein, R. Snyderman. Raven Press, New York 1988; 169–193
   Google Scholar
• Siraganian R.P. Mast cells and basophils. Inflammation: Basic Principles and Clinical Correlates, J.I. Gallin, I.M. Goldstein, R. Snyderman. Raven Press, New York 1988; 513–542
   Google Scholar
• Samuelsson B., Dahlen S.E., Lindgren J.A., Rouzer C.A., Serhan C.N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987; 237: 1171–1176
   PubMed Web of Science ®Google Scholar
• de Simone C., Ferrari M., Ferrarelli G., Rumi C., Pugnaloni L., Sorice F. The effects of substance P on human eosinophil receptors and functions. Ann. N.Y. Acad. Sci 1987; 496: 226–232
   Google Scholar
• McGillis J.P., Organist M.L., Payan D.G. Substance P and immunoregulation. Fed. Proc 1987; 46: 196–199
   PubMedGoogle Scholar
• Payan D.G., Brewster D.R., Goetzl E.J. Specific stimulation of human T lymphocytes by substance P. J. Immunol 1983; 131: 1613–1615
   PubMed Web of Science ®Google Scholar
• Stanisz A.M., Befus D., Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J. Immunol 1986; 136: 152–156
   PubMed Web of Science ®Google Scholar
• Payan D.G., Brewster D.R., Missirian-Bastien A., Goetzl E.J. Substance P recognition by a subset of human T lymphocytes. J. Clin. Invest 1984; 74: 1532–1539
   PubMed Web of Science ®Google Scholar
• Buck S.H., Burks T.F. The neuropharmacology of capsaicin: review of some recent observations. Pharmacol. Rev 1986; 38: 179–226
   PubMed Web of Science ®Google Scholar
• Helme R.D., Eglezos A., Dandie G.W., Andrews P.V., Boyd R.L. The effect of substance P on the regional lymph node antibody response to antigenic stimulation in capsaicin-pretreated rats. J. Immunol 1987; 139: 3470–3473
   PubMed Web of Science ®Google Scholar
• Quiron R., Shults C.W., Moody T.W., Pert D.B., Chase T.N., O'Donohue T.L. Autoradiographic distribution of substance P receptors in rat central nervous system. Nature 1983; 303: 714–716
   Google Scholar
• Mantyh P.W., Pinnock R.D., Downes C.P., Goedert M., Hunt S.P. Correlation between inositol phospholipid hydrolysis and substance P receptors in rat CNS. Nature 1984; 309: 795–797
   PubMed Web of Science ®Google Scholar
• Quirion R. Multiple tachykinin receptors. Trends Neurosci 1985; 8: 183–185
   Google Scholar
• Torrens Y., Beaujouan J.C., Saffroy M., Daguet de Montety M.C., Bergström L., Glowinski J. Substance P receptors in primary cultures of cortical astrocytes from the mouse. Proc. Natl. Acad. Sci. USA 1986; 83: 9216–9220
   PubMed Web of Science ®Google Scholar
• Wekerle H., Linington C., Lassmann H., Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci 1986; 8: 271–277
   Google Scholar
• Fontana A., Kristensen F., Dula R., Gemsa D., Weber E. Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J. Immunol 1982; 129: 2413–2419
   PubMed Web of Science ®Google Scholar
• Hartung H.P., Toyka K.V. Phorbol diester TPA elicits prostaglandin E release from cultured rat astrocytes. Brain Research 1987; 417: 347–349
   Google Scholar
• Hartung H.P., Toyka K.V. Leukotriene production by cultured astroglial cells. Brain Research 1987; 435: 367–370
   Google Scholar
• Hartung H.P., Heininger K., Schäfer B., Toyka K.V. Substance P and astrocytes: stimulation of the cyclo-oxygenase pathway of arachidonic acid metabolism. FASEB J 1988; 2: 48–51
   PubMed Web of Science ®Google Scholar
• Payan D.G., Brewster D.R., Missirian-Bastien A., Goetzl E.J. Substance P recognition by a subset of human T lymphocytes. J. Clin. Invest 1984; 74: 1532–1539
   PubMed Web of Science ®Google Scholar
• Payan D.G., Brewster D.R., Goetzl E.J. Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts. J. Immunol 1984; 133: 3260–3265
   PubMed Web of Science ®Google Scholar
• Payan D.G., McGillis J.P., Organist M.L. Binding characteristics and affinity labeling of protein constituents of the human IM-9 lymphoblast receptor for substance P. J. Biol. Chem 1986; 261: 14321–14329
   PubMed Web of Science ®Google Scholar
• McGillis J.P., Organist M.L., Scriven K.H., Payan D.G. Purification of the 33,000-dalton ligand binding-protein constituent of the lymphoblast substance P receptor. J. Neuroscience Res 1987; 18: 190–194
   Google Scholar
• Stanisz A.M., Scicchitano R., Dazin P., Bienenstock J., Payan D.G. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J. Immunol 1987; 139: 749–754
   PubMed Web of Science ®Google Scholar
• Wiedemann C.J., Sertl K., Pert C.B. Substance P receptors in rat spleen; characterization and autoradiographic distribution. Blood 1986; 68: 1398–1401
   Google Scholar
• Wiedemann C.J., Sertl K., Pert C.B. Neuropeptides and the immune system. Substance P receptors in bronchus-associated lymphoid tissue of rat. Ann. N.Y. Acad. Sci 1987; 496: 205–210
   Google Scholar
• Nishizuka Y. Turnover of inositol phospholipids and signal transduction. Science 1984; 225: 1365–1370
   PubMed Web of Science ®Google Scholar
• Nahorski S.R., Kendall D.A., Batty I. Receptors and phosphoinositide metabolism in the central nervous system. Biochem. Pharmacol 1986; 35: 2447–2453
   PubMed Web of Science ®Google Scholar
• O'Flaherty J. Phospholipid metabolism and stimulus-receptor coupling. Biochem. Pharmacol 1987; 36: 407–412
   PubMed Web of Science ®Google Scholar
• Watson S.P., Downes C.P. Substance P induced hydrolysis of inositol phospholipids in guinea-pig ileum and rat hypothalamus. Eur. J. Pharmacol 1983; 93: 245–253
   PubMed Web of Science ®Google Scholar
• Payan D.G., McGillis J.P., Renold F.K., Mitsuhashi M., Goetzl E.J. Neuropeptide modulation of leukocyte function. Ann. N.Y. Acad. Sci 1987; 496: 182–191
   PubMed Web of Science ®Google Scholar
• Payan D.G. Receptor-mediated mitogenic effects of substance P on cultured smooth muscle cells. Biochem. Biophys. Res. Comm 1985; 130: 104–109
   PubMed Web of Science ®Google Scholar
• Saria S., Lundberg J.M., Skofitsch G., Lembeck F. Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge. Naunyn Schmiedebergs Arch. Pharmacol 1983; 324: 212–218
   PubMed Web of Science ®Google Scholar
• Pernow B. Role of tachykinins in neurogenic inflammation. J. Immunol 1985; 135: 812s–815s
   PubMed Web of Science ®Google Scholar
• Holmdahl G., Hakanson R., Leander S., Rosell S., Folkers K., Sundler F. A substance P antagonist, (D-Pro2, D-Trp7.9)SP, inhibits inflammatory responses in the rabbit eye. Science 1981; 214: 1029–1031
   PubMed Web of Science ®Google Scholar
• Goetzl E.J., Chernov T., Renold F., Payan D.G. Neuropeptide regulation of the expression of immediate hypersensitivity. J. Immunol 1985; 135: 802s–805s
   Web of Science ®Google Scholar
• Levine J.D., Clark R., Devor M., Helms C., Moskowitz M.A., Basbaum A. Intraneuronal substance P contributes to the severity of exerpimental arthritis. Science 1984; 226: 547–549
   PubMed Web of Science ®Google Scholar
• Lotz M., Carson D.A., Vaughan J.H. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 1987; 235: 893–895
   PubMed Web of Science ®Google Scholar
• Kimball E.S., Fisher M.C. Potentiation of IL-1 induced balb/3T3 fibroblast proliferation by substance P. Ann N.Y. Acad. Sci 1988; 540: 681–683
   Google Scholar
• Anand P., McGregor G.P., Gibson S.J., Maden M., Polak J.M., Bloom S.R. Increase of substance P-like immunoreactivity in the peripheral nerve of the axolotl after injury. Neurosci. Lett 1987; 82: 241–245
   Google Scholar
• Serra M.C., Bazzoni F., della Bianca V., Greskowiak M., Rossi F. Activation of human neutrophils by Substance P. J. Immunol 1988; 141: 2118–2124
   PubMed Web of Science ®Google Scholar
• Lotz M., Vaughan J.H., Carson D.A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241: 1218–1221
   PubMed Web of Science ®Google Scholar